Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 9:11:143-152.
doi: 10.2147/CEG.S140655. eCollection 2018.

Systemic inflammatory response syndrome and model for end-stage liver disease score accurately predict the in-hospital mortality of black African patients with decompensated cirrhosis at initial hospitalization: a retrospective cohort study

Affiliations

Systemic inflammatory response syndrome and model for end-stage liver disease score accurately predict the in-hospital mortality of black African patients with decompensated cirrhosis at initial hospitalization: a retrospective cohort study

Alassan Kouamé Mahassadi et al. Clin Exp Gastroenterol. .

Abstract

Background: Systemic inflammatory response syndrome (SIRS) and model for end-stage liver disease (MELD) predict short-term mortality in patients with cirrhosis. Prediction of mortality at initial hospitalization is unknown in black African patients with decompensated cirrhosis.

Aim: This study aimed to look at the role of MELD score and SIRS as the predictors of morbidity and mortality at initial hospitalization.

Patients and methods: In this retrospective cohort study, we enrolled 159 patients with cirrhosis (median age: 49 years, 70.4% males). The role of Child-Pugh-Turcotte (CPT) score, MELD score, and SIRS on mortality was determined by the Kaplan-Meier method, and the prognosis factors were assessed with Cox regression model.

Results: At initial hospitalization, 74.2%, 20.1%, and 37.7% of the patients with cirrhosis showed the presence of ascites, hepatorenal syndrome, and esophageal varices, respectively. During the in-hospital follow-up, 40 (25.2%) patients died. The overall incidence of mortality was found to be 3.1 [95% confidence interval (CI): 2.2-4.1] per 100 person-days. Survival probabilities were found to be high in case of patients who were SIRS negative (log-rank test= 4.51, p=0.03) and in case of patients with MELD score ≤16 (log-rank test=7.26, p=0.01) compared to the patients who were SIRS positive and those with MELD score >16. Only SIRS (hazard ratio (HR)=3.02, [95% CI: 1.4-7.4], p=0.01) and MELD score >16 (HR=2.2, [95% CI: 1.1-4.3], p=0.02) were independent predictors of mortality in multivariate analysis except CPT, which was not relevant in our study. Patients with MELD score >16 experienced hepatorenal syndrome (p=0.002) and encephalopathy (p=0.001) more frequently than that of patients with MELD score ≤16. SIRS was not useful in predicting complications.

Conclusion: MELD score and SIRS can be used as tools for the prediction of mortality in black African patients with decompensated cirrhosis.

Keywords: Africa; MELD; SIRS; cirrhosis; mortality.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Survival plots of patients according to SIRS (A) and MELD score (B). MELD score was computed for 148 patients. Abbreviations: MELD, model for end-stage liver disease; SIRS, systemic inflammatory response syndrome.
Figure 2
Figure 2
AUROCs of MELD score, Child–Pugh, and the combination of SIRS and MELD score in parallel and sequential testing for the prediction of mortality. Notes: AUROCs were calculated with logistic regression in which MELD and Child–Pugh were used as continuous variables. MELD U SIRS: parallel testing. MELD ∩ SIRS: serial testing. MELD ∩ SIRS was not included in multiple comparisons involving MELD score, Child–Pugh–Turcotte, and MELD U SIRS as the sample size was not identical (n=67). MELD-Na was not included. Abbreviations: MELD, model for end-stage liver disease; SIRS, systemic inflammatory response syndrome; AUROCs, Area under receiver operating characteristic curves.

References

    1. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371(9615):838–851. - PMC - PubMed
    1. Planas R, Montoliu S, Ballesté B, et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 2006;4(11):1385–1394. - PubMed
    1. Tandon P, Garcia-Tsao G. Bacterial infection, sepsis and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28(1):26–42. - PubMed
    1. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis. A systematic review of 118 studies. J Hepatol. 2006;44(1):217–231. - PubMed
    1. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatol. 2000;31(4):864–871. - PubMed

LinkOut - more resources